companydata.dkNOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2016
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -77,546 and a net result of DKK -61,067 compared with DKK -69,047 the year before. Equity amounted to DKK 770,230,537. The solvency ratio was 100%.
- Gross Profit
- -77,546 kr.
- Profit/Loss
- -61,067 kr.
- Equity
- 770,230,537 kr.
- Total Assets
- 770,273,394 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -78 t. | -61 t. | 770.2 mio. | - |
| 2015 | - | -90 t. | -69 t. | 770.3 mio. | - |
How creditworthy is NOVOZYMES BIOINDUSTRIAL CHINA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of September 16, 2016, Randi Camilla Kinch Jensen is registered as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 16, 2016, Benny Dalgaard Loft has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2015. Gross profit came to DKK -89,648, and the net result was DKK -69,047.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.